Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
4.400
+0.540 (13.99%)
At close: Jul 23, 2025, 4:00 PM
4.450
+0.050 (1.14%)
Pre-market: Jul 24, 2025, 5:09 AM EDT
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $8.52 million as of July 23, 2025. Its market cap has decreased by -56.09% in one year.
Market Cap
8.52M
Enterprise Value
6.08M
1-Year Change
-56.09%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $8.52M, a decrease of -96.60%. That is a compound annual growth rate of -25.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2025 | 7.50M | -44.03% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | -57.31% |
| Mar 31, 2014 | 250.40M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.04B |
| Johnson & Johnson | 404.05B |
| AbbVie | 330.51B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 258.65B |
| Novartis AG | 224.80B |
| Abbott Laboratories | 218.75B |
| AstraZeneca | 216.82B |